Benzinga's M&A Chatter for Thursday September 18, 2014

The following are the M&A deals, rumors and chatter circulating on Wall Street for Thursday September 18, 2014:

:

SAP SE

and Concur Technologies, Inc.

announced Thursday, that SAP subsidiary, SAP America, has agreed to acquire Concur for $129 per share. The deal has an enterprise value of approximately US$8.3 billion, and will be funded from a credit facility agreement of up to €7 billion to cover the purchase price, target debt refinancing and acquisition-related costs.

reported on September 9, that Concur was exploring a sale and mentioned SAP and Oracle

as potential acquirers. Concur Technologies shares closed Thursday at $107.80, and traded almost 20% higher, after-hours.

:

Shares of SodaStream International Ltd.

rose Thursday in the premarket,

, that Diageo

, KKR

and SABMiller

could be interested in the Israeli maker of carbonated beverage machines. On Wednesday,

reported a possible deal with a British fund that could be worth $840 million. A spokesperson for SodaStream was not available for comment SodaStream shares closed Thursday at $32.49, a gain of 2%.

:

Shares of Transcanada Corp.

surged higher Thursday, on a report from

, that some of the company's major shareholders have been contacted by hedge funds, regarding a potential break-up of the company. Daniel Loeb's Third Point, is one of the hedge funds that has looked at Transcanada, according to people familiar with the matter. According to sources, Loeb has built up a stake in TransCanada. Third Point declined comment on the report. Transcanada Corp. closed Thursday at $55.52, gaining about 3.5% on 8 times average volume.

:

Shares of AOL, Inc.

spiked higher Thursday, on comments from BGC, that the company could be acquired by Yahoo! Inc.

for as much as $60.00 per share. Spokespersons for the companies were not available for comment. AOL closed Thursday at $43.66, a gain of more than 6%.

:

Shares of Vitamin Shoppe, Inc.

and GNC Holdings, Inc.

moved sharply higher Thursday, on a report from

that an activist investor has held conversations with the Vitamin Shoppe board, regarding a potential sale, according to sources. The shareholder had urged VSI to sell either to rival GNC or to a private equity firm, the sources said. A spokesperson for Vitamin Shoppe was not available for comment. Vitamin Shoppe closed Thursday at $45.44, a gain of almost 5%, while GNC shares also rose almost 5% to close at $41.02.